Related Experiment Video
Updated: Mar 9, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
Published on: May 16, 2012
Micro-RNA-204 Participates in TMPRSS2/ERG Regulation and Androgen Receptor Reprogramming in Prostate Cancer
Krassimira Todorova1, Metodi V Metodiev2, Gergana Metodieva2
1Institute of Biology and Immunology of Reproduction "Acad. Kiril Bratanov", Laboratory of Reproductive OMICs Technologies, Bulgarian Academy of Sciences, 73 Tsarigradsko shosse blvd, 1113, Sofia, Bulgaria.
Abstract:
Cancer progression is driven by genome instability incurred rearrangements such as transmembrane protease, serine 2 (TMPRSS2)/v-ets erythroblastosis virus E26 oncogene (ERG) that could possibly turn some of the tumor suppressor micro-RNAs into pro-oncogenic ones. Previously, we found dualistic miR-204 effects, acting either as a tumor suppressor or as an oncomiR in ERG fusion-dependent manner. Here, we provided further evidence for an important role of miR-204 for TMPRSS2/ERG and androgen receptor (AR) signaling modulation and fine tuning that prevents TMPRSS2/ERG overexpression in prostate cancer. Based on proximity-based ligation assay, we designed a novel method for detection of TMPRSS2/ERG protein products. We found that miR-204 is TMPRSS2/ERG oncofusion negative regulator, and this was mediated by DNA methylation of TMPRSS2 promoter. Transcriptional factors runt-related transcription factor 2 (RUNX2) and ETS proto-oncogene 1 (ETS1) were positive regulators of TMPRSS2/ERG expression and promoter hypo-methylation. Clustering of patients' sera for fusion protein, transcript expression, and wild-type ERG transcript isoforms, demonstrated not all patients harboring fusion transcripts had fusion protein products, and only few fusion positive ones exhibited increased wild-type ERG transcripts. miR-204 upregulated AR through direct promoter hypo-methylation, potentiated by the presence of ERG fusion and RUNX2 and ETS1. Proteomics studies provided evidence that miR-204 has dualistic role in AR cancer-related reprogramming, promoting prostate cancer-related androgen-responsive genes and AR target genes, as well as AR co-regulatory molecules. miR-204 methylation regulation was supported by changes in molecules responsible for chromatin remodeling, DNA methylation, and its regulation. In summary, miR-204 is a mild regulator of the AR function during the phase of preserved AR sensitivity as the latter one is required for ERG-fusion translocation.
Insights
MicroRNA-204 (miR-204) regulates TMPRSS2/ERG oncofusion and androgen receptor (AR) signaling in prostate cancer. It acts as a tumor suppressor by inhibiting TMPRSS2/ERG and upregulating AR, with implications for cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer progression involves genome instability and rearrangements like TMPRSS2/ERG fusions.
- MicroRNAs (miRNAs) can exhibit dual roles, acting as tumor suppressors or oncogenes.
- Previous studies indicated miR-204 has context-dependent effects in ERG fusion-positive cancers.
Purpose of the Study:
- To investigate the role of miR-204 in modulating TMPRSS2/ERG and androgen receptor (AR) signaling in prostate cancer.
- To elucidate the regulatory mechanisms of miR-204 on TMPRSS2/ERG expression and AR signaling.
- To develop a novel method for detecting TMPRSS2/ERG protein products.
Main Methods:
- Proximity-based ligation assay for TMPRSS2/ERG protein detection.
- Analysis of DNA methylation, promoter activity, and gene expression.
- Proteomics to study miR-204's role in AR reprogramming.
- Patient serum analysis for fusion transcripts and protein products.
Main Results:
- miR-204 negatively regulates TMPRSS2/ERG oncofusion via DNA methylation of the TMPRSS2 promoter.
- RUNX2 and ETS1 promote TMPRSS2/ERG expression and promoter hypomethylation.
- miR-204 upregulates AR by direct promoter hypomethylation, potentiated by ERG fusion, RUNX2, and ETS1.
- miR-204 exhibits a dual role in AR reprogramming, promoting androgen-responsive and AR target genes.
Conclusions:
- miR-204 acts as a negative regulator of TMPRSS2/ERG oncofusion in prostate cancer.
- miR-204 plays a significant role in modulating AR signaling, influencing AR target genes and co-regulatory molecules.
- miR-204's methylation-dependent regulation involves chromatin remodeling and DNA methylation pathways.
- miR-204 fine-tunes AR function during preserved AR sensitivity, crucial for ERG-fusion translocation.
Related Concept Videos
MicroRNAs
MicroRNAs
Master Transcription Regulators
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Expression at Multiple Steps
Abnormal Proliferation

